Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).

Biotechnology

Tectonic Therapeutic

Tectonic Therapeutic's headquarters in Watertown, MA, United States

Alise Reicin

Anthony Muslin

Geraldine Peters-Wiles

Barry Rubenstein

Daniel Lochner

Ashley Smith

Hitesh Soni, Ph.D., MBA

John Diener

Anthony (Tony) Muslin

Peter McNamara

Marc Schwabish

Terry Mcguire

Timothy A. Springer

Praveen Tipirneni

Stefan Vitorovic

Phillip Donenberg

The Research and Development team at Tectonic Therapeutic focuses on pioneering the discovery and development of antibodies and biologic drugs targeting G-protein Coupled Receptors (GPCRs). This team, composed of experts in cell biology, pharmacology, protein design, and antibody discovery, works collaboratively to advance innovative therapies, optimize protein design, and enhance drug efficacy for unmet medical needs.

Research and Development

The Development and Program Management team at Tectonic Therapeutic is responsible for orchestrating the strategic planning, development, and clinical progression of antibody and biologic drug candidates targeting G-protein Coupled Receptors (GPCRs). This team ensures cohesive project execution, oversees regulatory compliance, and drives the transition of therapies from preclinical stages through to clinical trials.

Development and Program Management

The Leadership Team at Tectonic Therapeutic is responsible for setting the strategic vision and direction of the company, guiding the development of innovative antibody and biologic drug discovery focused on GPCRs. This team collaborates across functions to drive operational efficiency, oversee product development, and foster partnerships that enhance the company’s growth and impact in the therapeutic landscape.

Leadership Team

The Finance Team at Tectonic Therapeutic, comprised of a Senior Accounting Manager, Executive Director of Finance & Controller, and SEC Reporting Manager, is responsible for managing financial planning, analysis, and reporting to ensure the company’s compliance with regulatory standards. They oversee budgeting, financial forecasting, and the preparation of financial statements to support Tectonic’s strategic initiatives in drug discovery.

Tectonic Therapeutic

Org chart

Board & advisors

Teams

Research and Development

Development and Program Management

Leadership Team

Finance Team

Offices

Similar companies